Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed a binding term sheet with a prominent pharmaceutical and healthcare company in Korea, granting exclusive Korean rights to OCU400, its experimental …
Ocugen Secures Licensing Agreement for OCU400 in Korea Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the European launch of its OviTex Inguinal Reinforced Tissue Matrix, the first reinforced tissue matrix explicitly designed for laparoscopic and …
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its upcoming inclusion in the Russell 3000® Index and the Russell 2000® Index following the annual reconstitution of the Russell indexes. This …
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leader in soft tissue reconstruction innovations, has announced the appointment of Jeffrey Blizard as its new President, effective immediately. Blizard, who …
TELA Bio Names Jeffrey Blizard as President to Drive Strategic Growth Read MoreWAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the initiation of a Phase 2 trial for its investigational drug bosakitug (ATI-045), targeting moderate-to-severe atopic dermatitis (AD). This randomized, …
Aclaris Therapeutics Launches Phase 2 Trial for Promising Atopic Dermatitis Treatment Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced its participation in two healthcare conferences in June:
Aclaris Therapeutics to Present at Two Major Healthcare Conferences in June 2025 Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and Chief Executive Officer, Jayson Rieger, PhD, MBA, will speak at the prestigious Jefferies Global Healthcare …
Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced the immediate appointment of Ashley Kline as Chief Commercial Officer. With a proven history of launching therapies for rare diseases, …
Palvella Therapeutics Names Ashley Kline Chief Commercial Officer Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) for its investigational therapy OCU410ST, aimed …
Ocugen Receives Rare Pediatric Disease Designation for OCU410ST Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) has announced that its Board of Directors recently approved a $0.07 per share dividend for the second quarter of 2025.
Bentley Systems Declares $0.07 Dividend for Q2 2025 Read More